Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation — MMP

Photosensitivity Disorders Clinical Trial

Official title:
Conventional Microneedling Compared to Microneedling Associated With 5-FU Infusion (Microinfusion of Medication Into the Skin - MMP) for Idiopathic Guttate Hypomelanosis (IGH) Repigmentation

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine whether 5-FU infusion (Microinfusion of Medicine Percutaneously - MMP) is effective for Idiopathic Guttate Hypomelanosis (IGH) repigmentation compared to conventional Microneedling. MMP is a procedure done with tattoo devices using medication in place of ink.

Clinical Trial Description

Split body design. Each upper limb will receive a different intervention (experimental or placebo) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02904564
Study type	Interventional
Source	Clinica Dermatologica Arbache ltda
Contact
Status	Recruiting
Phase	Phase 4
Start date	August 20, 2016
Completion date	January 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01776983` - Skin Aging in Renal Transplant Patients	Phase 4
Completed	`NCT01491620` - Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte	N/A
Completed	`NCT00204542` - Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head	Phase 4